Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Castelnauv Le Lez

4 clinical trials in Castelnauv Le Lez, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Castelnauv Le Lez at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Castelnauv Le Lez

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Centre Hospitalier De Versailles
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen - Cilag International

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Castelnauv Le Lez

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on innovative treatments for bladder cancer, specifically targeting non-muscle invasive cases. Research aims to evaluate new therapeutic combinations for patients who haven't responded to conventional treatments.

  • Bladder Cancer Therapeutics
  • Treatment-Resistant Cases
  • Combination Therapy Approaches

Studies include evaluation of complete response rates and disease-free survival in patients with specific bladder cancer presentations, particularly those with carcinoma in situ.

02 Urology Innovations

Advanced research in urothelial carcinoma management, exploring alternative solutions for patients who are either ineligible for or have chosen not to undergo radical surgical interventions.

  • Non-Surgical Alternatives
  • Novel Treatment Methods
  • Patient-Centered Approaches

The research emphasizes developing treatment options for those who have not responded to standard intravesical therapy.

03 Therapeutic Development

Investigation of targeted therapies for high-risk bladder cancer, combining innovative drug delivery systems with immunotherapy approaches.

  • Drug Delivery Innovation
  • Immunotherapy Research
  • High-Risk Patient Care

Focus on developing effective treatments for patients with high-grade disease presentations, including both isolated and combination therapy approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.